PTC Therapeutics (NASDAQ:PTCT) reported top-line results from a 24-month interim analysis of the PIVOT-HD long-term extension (LTE) study evaluating Votoplam in Huntington’s disease, highlighting what ...

Fresh off a major clinical win, Revolution Medicines alleges that Erasca’s pancreatic cancer drug infringes on key patent ...

Abstract: This paper presents a high-speed comparator which employs a novel regeneration latch to enhance the comparison process. The regeneration stage employs an innovative mechanism that reduces ...

Could drugs like Mounjaro treat people with cannabis use disorder? They might. Preliminary research indicates they may stop ...

Manipulators often use subtle phrases that sound kind but are actually forms of gaslighting, love bombing, and emotional ...

In many incretin-based interventions, reductions in muscle-related indices exceed prespecified benchmarks, according to a review published online April 17 in th ...

No increase in subtrochanteric or diaphyseal femur fractures was seen with denosumab use compared with bisphosphonates in 4 ...

This year’s American Academy of Neurology meeting included a presentation that could one day set a new treatment standard for ...

LED candles are neat, but they’re very suboptimal for wish-making: you can’t blow them out. Unless you take the circuit from ...

Targeted multidisciplinary AMS is associated with improved prescribing quality and reduced broad-spectrum antibiotic use, new ...

Scandinavian Real Heart today announced a new in vitro study backs its Realheart total artificial heart (TAH) system.